Shanghai Ruijian Capital Management
Shanghai Ruijian Capital Management Co. focuses on fostering a collaborative and innovative environment that emphasizes integration, friendship, and entrepreneurial spirit. The company is dedicated to supporting the development of businesses and projects, aiming to create opportunities for growth and partnership within various sectors. By prioritizing a culture of cooperation and dynamic engagement, Ruijian Capital seeks to contribute positively to the broader economic landscape, facilitating connections and promoting sustainable success for its stakeholders.
4 past transactions
Xinruili
Series B in 2023
Xinruili provides automotive aftermarket services.
Xinruili
Series A in 2021
Xinruili provides automotive aftermarket services.
Wuxi Vision Pro
Series B in 2018
Wuxi Vision Pro Ltd. is a prominent manufacturer of ophthalmic medical devices, specializing in the research, development, production, and marketing of intraocular lenses and related products. Established in 2010 and headquartered in Wuxi, China, with an additional location in Irvine, California, the company is dedicated to advancing eye care worldwide. Its portfolio features high refractive index hydrophobic acrylic biocompatible materials, which are crucial for the production of sophisticated ophthalmic devices. Wuxi Vision Pro focuses on developing high-quality lenses aimed at treating various ophthalmic conditions, including cataracts, glaucoma, and retinal diseases. The company prides itself on maintaining rigorous standards in research, development, and quality control to ensure the efficacy and reliability of its products for the global ophthalmic industry.
Yaocaimaimai.com
Series A in 2017
Yaocaimaimai.com is an e-commerce platform that specializes in trading Chinese herbal medicines.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.